Related Experiment Video
Updated: Jan 11, 2026
Antimicrobial Characterization of Advanced Materials for Bioengineering Applications
Published on: August 4, 2018
Antimicrobial Efficacy of a Taurolidine-Based Antimicrobial Compound on Contaminated Surfaces Simulated in a
Benito Baldauf1,2, Hendrik Bonnemeier1,2,3, Ernest W Lau4
1Institute of life science, University of Applied Sciences Bremerhaven, 27568, Bremerhaven, Germany.
Abstract:
Implantable medical devices, including cardiac electronic implants, joint prostheses, and breast implants, are essential to modern healthcare but remain susceptible to infection from microbial contamination during placement. Staphylococcus spp. and Candida albicans are the predominant pathogens, often causing severe complications, increased mortality, and substantial healthcare costs. With antibiotic resistance on the rise, intraoperative surface disinfection has emerged as a critical yet underutilized preventive strategy. Taurolidine, a broad-spectrum antimicrobial with a strong safety profile and no known resistance, can be applied directly to both tissues and device surfaces. To replicate intraoperative decontamination, taurolidine-saturated swabs are tested under standardized mechanical wiping using the European Norm EN 16615 "4-field test." The model reproduced short contact times and organic load conditions reflective of clinical practice, enabling assessment of both chemical and mechanical antimicrobial effects. Taurolidine achieved >5 log10 reductions in Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans, and >4 log10 for Enterococcus hirae. The observed activity demonstrated a surface-driven, enzyme-independent mechanism involving spontaneous release of reactive N-methylol functional groups that disrupt microbial membranes. Taurolidine's enzyme-independent antimicrobial mechanism distinguishes it from solvent- or oxidant-based disinfectants. These results support taurolidine as a potential adjunctive prophylactic agent to reduce device-related infections during implantation procedures.
Insights
Taurolidine effectively reduced common device-associated bacteria and fungi on surfaces in a simulated surgical setting. This broad-spectrum antimicrobial shows promise for preventing implantable medical device infections.
Area of Science:
- Medical Microbiology
- Biomaterials Science
- Infectious Disease Prevention
Background:
- Implantable medical devices are crucial but prone to microbial contamination during placement, leading to severe infections.
- Staphylococcus spp. and Candida albicans are primary pathogens, causing significant morbidity, mortality, and healthcare costs.
- Rising antibiotic resistance necessitates effective intraoperative surface disinfection strategies.
Purpose of the Study:
- To evaluate taurolidine's efficacy as an intraoperative surface disinfectant for implantable medical devices.
- To assess taurolidine's antimicrobial activity under conditions mimicking clinical surgical procedures.
Main Methods:
- Utilized the European Norm EN 16615 '4-field test' with taurolidine-saturated swabs for standardized mechanical wiping.
- Simulated intraoperative decontamination conditions, including short contact times and organic load.
- Quantified microbial reductions for Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans, and Enterococcus hirae.
Main Results:
- Taurolidine achieved >5 log10 reductions against Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans.
- Achieved >4 log10 reduction for Enterococcus hirae.
- Demonstrated an enzyme-independent mechanism involving reactive N-methylol groups disrupting microbial membranes.
Conclusions:
- Taurolidine exhibits potent, broad-spectrum antimicrobial activity effective in a simulated intraoperative setting.
- Its unique enzyme-independent mechanism differentiates it from conventional disinfectants.
- Taurolidine is a promising adjunctive prophylactic agent to reduce implant-associated infections.
